AK2 p.Ser129Asn
c.386G>A · rs61750965 · VCV517906
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1302 | likely benign |
|---|---|---|
| REVEL | 0.128 | moderately benign-leaning |
| SaProt | LLR -6.83 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 1.8 | GERP 1.8, phastCons 0.99 |
| Regional constraint | o/e 0.85 | unconstrained · MANE · 24 kb · p 0.0069 · regional, not allelic |
| Overall | ||
| CADD | 18.33 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| European (non-Finnish)grpmax | 0.663% | 151 |
| Ashkenazi Jewishnot grpmax-eligible | 0.645% | 155 |
| South Asian | 0.549% | 182 |
| Middle Eastern | 0.511% | 196 |
| Remaining individualsnot grpmax-eligible | 0.503% | 199 |
| African / African-American | 0.125% | 798 |
| Admixed American | 0.085% | 1,177 |
| Finnishnot grpmax-eligible | 0.0437% | 2,287 |
| East Asian | 0.00223% | 44,886 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- AK2
- Protein
- p.Ser129Asn
- Coding
- c.386G>A
- MANE Select
- NM_001625
- dbSNP
- rs61750965
- Type
- single nucleotide variant
- Location
- chr1:33021406 (GRCh38)
- Gene constraint
- LOEUF 0.954 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 90.49 · 3 PDB
- Residue 129
- a β-strand
Disease context
reticular dysgenesis — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Reticular dysgenesis (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Infancy, Neonatal
- Prevalence
- <1 / 1 000 000 (Europe)
Similar variants
- AK2 p.Ser129= Likely benign ★ same residue
- AK2 p.Ser129Arg Uncertain significance ★ ⚠ same residue
- AK2 c.330+5G>A Pathogenic ★★ same condition
- AK2 c.498+1G>A Pathogenic/Likely pathogenic ★★ same condition
- AK2 p.Ala182Asp Pathogenic/Likely pathogenic ★★ same condition
- AK2 p.Arg103Trp Pathogenic/Likely pathogenic ★★ same condition
- AK2 p.Arg175Pro Likely pathogenic ★★ same condition
- AK2 p.Met1Val Pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ak2-p-ser129asn (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown